Clinical implications of 5-FU modulation

ONCOLOGY

Volumn 13, Issue 7 SUPPL., 1999, Pages 22-25

  Rustum, Youcef M ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYURIDINE PHOSPHATE; FLUOROURACIL; FOLINATE CALCIUM;

BONE MARROW TOXICITY; BREAST CANCER; CLINICAL TRIAL; COLON CARCINOMA; COLORECTAL CANCER; CONFERENCE PAPER; DIARRHEA; DNA SYNTHESIS; DOSE RESPONSE; DRUG RESISTANCE; DRUG RESPONSE; HUMAN; INSTRUMENTATION; INTRAVENOUS DRUG ADMINISTRATION; METHODOLOGY; PHASE 3 CLINICAL TRIAL; PREDICTION; STOMATITIS; TARGET CELL;

ANTIMETABOLITES, ANTINEOPLASTIC; BREAST NEOPLASMS; COLORECTAL NEOPLASMS; DNA, NEOPLASM; DRUG COMBINATIONS; DRUG SYNERGISM; FEMALE; FLUOROURACIL; HUMANS; LEUCOVORIN; THYMIDYLATE SYNTHASE;

EID: 0032775984     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (12)

1. Madajewicz S, Petrelli N, Rustum YM, et al: Phase I-II trial of high-dose calcium leucovorin and 5-fluorouracil in advanced colorectal cancer. Cancer Res 44:4667-4669, 1984.
2. Hines JD, Zakem MH, Adelstein DJ, et al: Treatment of advanced-stage colorectal adenocarcinoma with fluorouracil and high-dose leucovorin calcium: A pilot study. J Clin Oncol 6:142-146, 1988.
3. Hartmann KU, Heidelberg C: Studies on fluorinated pyrimidine. XIII-inhibition of thymidylate synthetase. J Biol Chem 236:3006-3013, 1961.
4. Houghton JA, Meroda SJ Jr, Phillips JO, et al: Biochemical determinants of responsiveness to 5-fluorouracil and its derivatives in xenografts of human colorectal adenocarcinoma in mice. Cancer Res 41:144-149, 1981.
5. Mandel HD: The incorporation of 5-fluorouracil in RNA and its molecular consequences. Prog Mol Subcell Biol 1:82-135, 1969.
6. Glazer RI, Lloyd LS: Association of cell lethality with incorporation of 5-fluorouracil and 5-fluorouridine into nuclear RNA in human colon carcinoma cells in culture. Mol Pharmacol 21:468-473, 1982.
7. Goldin A, et al: Estimation of antileukemic potency of antimetabolite aminopterin administered alone and in combination with citrovorum factor or folic acid. Cancer Res 13:843-850, 1553.
8. Sullivan RD: Antimetabolite-metabolite combination cancer chemotherapy. Cancer 12:1248-1262, 1959.
9. Friedkin M: Thymidylate synthetase. Adv Enzymol 38:253-292, 1973.
10. Huennekens FM, Duffy TH, Vitols KS: Folic acid metabolism and its disruption by pharmacologic agents. Natl Cancer Inst Monogr 5:1-8, 1987.
11. Moran RG, Keyomarsi K: Biochemical rationale for the synergism of 5-fluorouracil and folinic acid. Natl Cancer Inst Monogr 4:159-163, 1987.
12. Könne CH, Schöffski P, Wilke H, et al: Effective biomodulation by leucovorin of high dose infusion fluorouracil given as a weekly 24 hour infusion: Results of a randomized trial in patients with advanced colorectal cancer. J Clin Oncol 16:418-426, 1998.